Vertex Pharmaceuticals Stock Alpha and Beta Analysis
| VRTX Stock | USD 504.77 1.85 0.37% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Vertex Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Vertex Pharmaceuticals over a specified time horizon. Remember, high Vertex Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Vertex Pharmaceuticals' market risk premium analysis include:
Beta (0.01) | Alpha 0.15 | Risk 2.18 | Sharpe Ratio 0.0678 | Expected Return 0.15 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Vertex |
Vertex Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Vertex Pharmaceuticals market risk premium is the additional return an investor will receive from holding Vertex Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Vertex Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Vertex Pharmaceuticals' performance over market.| α | 0.15 | β | -0.01 |
Vertex Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Vertex Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Vertex Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Vertex Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Vertex Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vertex Pharmaceuticals shares will generate the highest return on investment. By understating and applying Vertex Pharmaceuticals stock market price indicators, traders can identify Vertex Pharmaceuticals position entry and exit signals to maximize returns.
Vertex Pharmaceuticals Return and Market Media
The median price of Vertex Pharmaceuticals for the period between Mon, Dec 16, 2024 and Sun, Mar 16, 2025 is 462.11 with a coefficient of variation of 7.17. The daily time series for the period is distributed with a sample standard deviation of 32.4, arithmetic mean of 451.85, and mean deviation of 28.55. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Salesforce and Google Cloud sign multi-billion dollar software deal which could affect how you use AI at work | 02/25/2025 |
2 | Vertex Pharmaceuticals Inc Announces Positive CHMP Opinio | 02/28/2025 |
3 | Fisher Asset Management LLC Acquires 2,886 Shares of Vertex Pharmaceuticals Incorporated | 03/04/2025 |
4 | Cannabis For Pain Relief Scientists Develop New Compound Without Mind-Altering Effects Alternative To Opioids | 03/06/2025 |
5 | Vertex Announces UK MHRA Approval of ALYFTREK , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis | 03/07/2025 |
6 | Lounge Lizard Unveils Informative Editorial on Harnessing Vertex AI Search for Websites | 03/10/2025 |
7 | ElevateBio taps Amazons genAI tools to design CRISPR therapeutics | 03/11/2025 |
8 | Why Vertex Pharmaceuticals Incorporated is the Best Pharma Stock to Buy According to Hedge Funds | 03/12/2025 |
9 | Why the Market Dipped But Vertex Pharmaceuticals Gained Today | 03/13/2025 |
About Vertex Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Vertex or other stocks. Alpha measures the amount that position in Vertex Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 58.94 | 57.82 | 53.31 | 58.29 | PTB Ratio | 5.32 | 5.96 | 6.32 | 7.39 |
Vertex Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Vertex Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vertex Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Vertex Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Vertex Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Vertex Pharmaceuticals' management manipulating its earnings.
| 5th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Vertex Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.